Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
EXPANDING THE FRONTIERS OF MULTIPLEXING BEYOND TRADITIONAL LIMITATIONS
About This Webinar
Join us for this interactive webinar and explore the new frontiers of multi-colour imaging: from image acquisition to analysis.
Agenda
- In this webinar, Cameron Nowell and his colleagues from Monash Institute of Pharmaceutical Sciences will share their experience in multiplexing and results they were able to achieve through clever confocal imaging acquisition, as well as by utilising other multiplexing modalities such as FLIM.
- Case #1 will demonstrate a unique method used in measuring spatial interactions in a tumour microenvironment of a triple-negative breast cancer.
- Case #2 will explore the ways the power of multiplexed imaging can be harnessed to investigate changes to immune cell population size and location within the intestinal wall in patients who are high risk of developing a potentially lethal infection named Hirschsprung Associated Enterocolitis.
- After their presentation, we will go in a detailed account of how the STELLARIS confocal platform from Leica Microsystems enables researchers to extend multiplexing capabilities through new and improved technologies: the next generation of White Light Lasers and Power HyD detectors for optimised excitation and emission including in near infrared range, fully integrated lifetime-based imaging approaches (TauSense) and Stimulated Emission Depletion (STED).
Who can view: Everyone
Webinar Price: Free
Featured Presenters
Head of Imaging, FACS and Analysis Core, Monash Institute of Pharmaceutical Sciences
Cameron has led the imaging and flow cytometry capabilities at MIPS since its inception 10 years ago. Cameron has been part of many and varied projects ranging from pharmacology to SARSCoV-2, honeybees and even coral growth. He has been an author on over 100 papers with >3100 citations in many high impact journals including Cell, Cancer Discovery, Nature Nano., Immunity and Nature Immunity.
BPharmSci Adv(Hons) PhD Student, Integrated Neurogenic Mechanisms Group Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences
Ashleigh is a final year PhD student studying in the Integrated Neurogenic Mechanisms lab. She
received her Bachelor of Pharmaceutical Science from Monash University in 2019 continuing on
to commence her PhD in 2020. Her research focuses on how the gut resident immune system
differs in children with the rare neuropathy, Hirschsprung Disease.
received her Bachelor of Pharmaceutical Science from Monash University in 2019 continuing on
to commence her PhD in 2020. Her research focuses on how the gut resident immune system
differs in children with the rare neuropathy, Hirschsprung Disease.
BMedChem (Hons), PhD Candidate, Monash Institute of Pharmaceutical Sciences
Annabel completed a Bachelor of Medicinal Chemistry at the University of Technology Sydney
in 2019, followed by her Bachelor of Medicinal Chemistry at the Children’s Medical Research
Institute in 2020. In her PhD, Annabel uses confocal microscopy and fluorescent lineage
tracing technologies to characterise the interactions between sympathetic nerves and
heterogenous cancer populations in the tumour microenvironment.
in 2019, followed by her Bachelor of Medicinal Chemistry at the Children’s Medical Research
Institute in 2020. In her PhD, Annabel uses confocal microscopy and fluorescent lineage
tracing technologies to characterise the interactions between sympathetic nerves and
heterogenous cancer populations in the tumour microenvironment.
Senior Applications Specialist, Leica Microsystems
Taryn has a PhD in Materials Science from University of South Australia. Her post-doctoral research at Monash University combined imaging with mass spectrometry for small molecule detection. Taryn joined Leica Microsystems in 2018 and is a Senior Applications Specialist for high end microscopy workflows and analysis solutions.
Hosted By
Attended
(55)
Recommended